Tag Archives: CADC

stock data

Related SFM Benzinga's Top Upgrades, Downgrades For March 21, 2017 Oppenheimer Weighs In On Sprouts Farmers As An 'In Play' Target Sprouts Farmers Market: Albertsons Is Shopping Around For A Deal (Seeking Alpha)

Thanks to volatility in food prices, Albertsons LLC's reported eye on a merger with Sprouts Farmers Market Inc (NASDAQ: SFM) could be a golden opportunity for the bigger chain to add the organic grocer to a business that currently includes Safeway stores, analysts said Tuesday.

stock data: China Advanced Construction Materials Group, Inc.(CADC)

Advisors’ Opinion:

  • [By Lisa Levin]

    China Advanced Constructn Mtrls Grp Inc (NASDAQ: CADC) shares shot up 225 percent to $7.15 after gaining 2.33 percent on Wednesday.

    Shares of Smart Global Holdings Inc (NASDAQ: SGH) got a boost, shooting up 29 percent to $36.98 after the company issued strong guidance. The company updated Q1 guidance, raising adjusted EPS from 79 cents-83 cents to 90 cents-93 cents. Sales guidance was raised from $225 million-$240 million to $250 million-$260 million.

stock data: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Novocure Ltd (NASDAQ: NVCR) shares shot up 22 percent to $7.27 after the company posted a narrower-than-expected Q3 loss.

    Shares of TriNet Group Inc (NYSE: TNET) got a boost, shooting up 15 percent to $20.43. TriNet reported Q3 earnings of $0.29 per share on revenue of $770.5 million.

stock data: Tandem Diabetes Care, Inc.(TNDM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Tandem Diabetes Care Inc (NASDAQ: TNDM) were down 58 percent to $2.25 after the company posted downbeat quarterly results.

    Cempra Inc (NASDAQ: CEMP) was down, falling around 59 percent to $7.69 after the FDA raised liver safety issues in its review of the company's experimental drug to treat community acquired pneumonia. Baird downgraded Cempra from Outperform to Underperform.

  • [By Paul Ausick]

    Tandem Diabetes Care Inc. (NASDAQ: TNDM) dropped nearly 26% Thursday, to post a new 52-week low of $1.15 after closing at $1.55 on Wednesday. The stock’s 52-week high is $11.30. Volume was more than 20 times the daily average of around 290,000. The company announced an underwritten secondary offering of 18 million shares at $1.25 per share.

  • [By Lisa Levin]

    Shares of Tandem Diabetes Care Inc (NASDAQ: TNDM) were down 37 percent to $2.97 after the company reported a proposed offering of common stock and series A and B warrants.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston
  • [By Lisa Levin]

    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares dropped 19 percent to $1.25. Tandem Diabetes Care priced its 18 million share offering at $1.25 per share.

stock data: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Chris Lange]

    Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from its Phase 2 trial of Sage-217 for the treatment of moderate to severe major depressive disorder (MDD).

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

  • [By Lisa Levin]

    SAGE Therapeutics Inc (NASDAQ: SAGE) shares shot up 73 percent to $159.39 after the company disclosed that Phase 2 trial of SAGE-217 met its primary endpoint.

stock data: Minerva Neurosciences, Inc(NERV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Minerva Neurosciences Inc (NASDAQ: NERV) shares shot up 194 percent to $10.39 after the company revealed positive top line results from a prospective Phase IIb, 12-week, randomized, double-blind, placebo-controlled parallel clinical study evaluating the efficacy, safety and tolerability of MIN-101 in patients with negative symptoms of schizophrenia.

stock market

Earnings Season Wrap Up- The last batch of third quarter earnings get announced this week, putting an end to another strong season. On Monday, Palo Alto Networks and Intuit report earnings. On Tuesday, Lowes, Dollar Tree, Salesforce and HP are scheduled to announce. And on Wednesday, John Deere reports its third quarter figures.

Tax Reform Update- After the House passed their version of the tax bill last Thursday, it’s now up to the Senate to have their say. Congressional Republicans are still aiming to have a bill on the President’s desk to sign by Christmas which means that changes should come sooner rather than later. A major change that just got proposed yesterday was the willingness to remove the provision that removes the ObamaCare individual mandate. Stay tuned to our Facebook page as these updates keep rolling in.

Economic Data Dump- Although the trading week is cut short by the holiday, the economic calendar is still quite full. On Tuesday, the National Association of Realtors report their U.S. existing home sales figures for October. This comes after last month when they reported the first decline in sales since July 2016. And then on Wednesday, U.S. durable goods orders are scheduled to be released as well as the Fed minutes from its Oct 31-Nov 1 meeting. Is a December rate hike still on the table? Find out Wednesday.

stock market: Nature's Sunshine Products, Inc.(NATR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

stock market: Graco Inc.(GGG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, industrials shares fell by 0.83 percent. Meanwhile, top losers in the sector included Graco Inc. (NYSE: GGG), down 9 percent, and Southwest Airlines Co (NYSE: LUV), down 11 percent.

  • [By Joel Elconin]

    At this time, the only relevant news to the Gold market and Gold stocks was the halt of Graco Inc. (NYSE: GGG), which was down $0.80 at $84.64 and just reopened at $82.20.

stock market: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Guggenheim’s Tony Butler and Kaitlin Sandor argue that Gilead Sciences (GILD) should buy Syndax Pharmaceuticals (SNDX), Corvus Pharmaceuticals (CRVS), and Tesaro (TSRO) to solve its problem of slowing sales:

  • [By Ben Levisohn]

    Who has PARP? A poly ADP-ribose polymerase inhibitor (PARPi) kills cancer cells by interfering tumor DNA repair pathway with the potential to treat ovarian, breast and prostate cancer. Studies have shown that patients with BRCA mutations (BRCAmut) respond to PARPi. AstraZenecas (AZN) PARPi was approved in 2014 whileClovis Oncology (CLVS) and Tesaro (TSRO) both have positive Phase III data. Clovis licensed its PARPi from Pfizer (PFE) in 2011 and Tesaro licensed its PARPi from Merck (MRK) in 2012, after Sanofis (SNY) PARPi (later demonstrated that it cannot block PARP) failed in Phase III in early 2011.

  • [By George Budwell]

    Unfortunately for Clovis and its shareholders, though, Astra’s Lynparza is currently underpriority review with the FDA as a maintenance therapy in ovarian cancer, andTesaro’s (NASDAQ:TSRO)rival PARP inhibitor Zejula gained an early approval– along with afar broader label than Rubraca — just this week.

  • [By Ben Levisohn]

    Shares of Tesaro (TSRO) are soaring today after the biotech company reported positive data for its treatment of ovarian cancer over the weekend. Credit Suisse analyst Alethia Young and team contend that “M&A remains in focus” for Tesaro following the data:

    Getty Images

    We are increasing our target price to $122 from $90 as we move to an M&A DCF valuation. We were at ESMO this weekend, and we believe the big takeaway on Tesaro data is that it works broadly in all 2L ovarian populations and safety looks solid. We also think the robustness of this data bodes well from PRIMA and QUADRA but are maintaining our POS here. We have looked at our model and also adjusted durations in first-line. We think Tesaro remains one of the most attractive and de-risked cancer assets in our landscape and the company has been cited in major press sources as a takeout target (Bloomberg, Investor Business Daily).

    We think M&A remains in focus for Tesaro. Our M&A DCF valuations range from $122 to $157 by our model. We have also built models for other cancers like NSCLC, SCLC, prostate, and others where PARP might be impactful. We assume 0% POS for now but we conservatively see at least another $1B in sales from PARP expansion. Tesaro has been cited in the press as a potential M&A target and is a company we frequently hear mentioned as a target from our conversations. We think the demand for late stage oncology assets is high, especially in the PARP space given the potential for activity across a range of tumors. For a large Pharma player who already has an oncology salesforce and large R&D infrastructure we could see SG&A synergies of 50-75% and R&D synergies of 15-30%. In our base case TSRO P&L we model a tax rate of 30% so there could be synergies here as well. Two additional key swing factors which might be included in a CVR are how much expansion from PARP in other cancers and immuno-oncology…

    Ex M&A,

  • [By Todd Campbell]

    The PARP battle is on. Following news that AstraZeneca’s (NYSE:AZN) PARP-inhibiting cancer drug Lynparza delivered a big win in phase 3 studies, all eyes now shift to how a potential Food and Drug Administration approval for Lynparza will reshape the commercial opportunity for competitor Tesaro Inc. (NASDAQ:TSRO).

  • [By Todd Campbell]

    Tesaro’s (NASDAQ:TSRO)ovarian cancer drug, niraparib, will begin competing for prescriptions earlier than expected. Niraparib, which will be sold under the brand name Zejula, notched FDA approval on Monday, more than three months ahead of its June 30 decision date. The early approval setsTesaro up for a fierce battle for market share withAstraZeneca (NYSE:AZN)and Clovis Oncology (NASDAQ:CLVS), both of which market drugs that work similarly to Zejula.

stock market: China Advanced Construction Materials Group, Inc.(CADC)

Advisors’ Opinion:

  • [By Lisa Levin]

    China Advanced Constructn Mtrls Grp Inc (NASDAQ: CADC) shares shot up 225 percent to $7.15 after gaining 2.33 percent on Wednesday.

    Shares of Smart Global Holdings Inc (NASDAQ: SGH) got a boost, shooting up 29 percent to $36.98 after the company issued strong guidance. The company updated Q1 guidance, raising adjusted EPS from 79 cents-83 cents to 90 cents-93 cents. Sales guidance was raised from $225 million-$240 million to $250 million-$260 million.

stock market: Intrepid Potash, Inc(IPI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, basic materials shares gained by 1.74 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), and L.B. Foster Co (NASDAQ: FSTR).

  • [By Lisa Levin]

    Monday afternoon, the basic materials shares surged 0.57 percent. Meanwhile, top gainers in the sector included CF Industries Holdings, Inc. (NYSE: CF), up 7 percent, and Intrepid Potash, Inc. (NYSE: IPI), up 7 percent.

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Intrepid Potash, Inc. (NYSE: IPI) and L.B. Foster Co (NASDAQ: FSTR).

top stocks to invest in now

Stocks rose to new highs today after President Donald J. Trump promised a ‘phenomenal’ tax package in a meeting with airline executives today.

Getty Images

The S&P 500 rose 0.6% to 2,307.87 today, while the Dow Jones Industrial Average gained 118.06 points, or 0.6%, 20,172.40. The Nasdaq Composite rallied0.6% to 5,715.18. All three indexes closed at record highs.

Gluskin Sheff’s David Rosenberg writes that his biggest fear is the lack of fear:

MY BIGGEST FEAR…is the lack of fear itself.

The National Federation of Independent Business index that assesses small business economic expectations has gone from 0 in September to 50 in December. That is close to an all-time high and the surge in four short months is without precedent. This is one measure of what is being priced in at the current time…

top stocks to invest in now: Cartesian, Inc.(CRTN)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggestedsmall cap professional services and technical solutions stock Cartesian Inc (NASDAQ: CRTN) as a long/bullish trade:

top stocks to invest in now: Nordic American Offshore Ltd(NAO)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nordic American Offshore Ltd. (NYSE: NAO) dropped nearly 49% Friday, to post a new 52-week low of $1.05 after closing at $2.05 on Thursday. The stock’s 52-week high is $5.69. Volume was more than 100 times the daily average of around 90,000 shares. The company priced a secondary offering of 40 million shares at just $1.25 per share this morning.

  • [By Lisa Levin]

    Nordic American Offshore Ltd. (NYSE: NAO) shares dropped 39 percent to $1.245. Nordic American Offshore priced its upsized offering of 40 million shares at $1.25 per share.

  • [By Paul Ausick]

    Nordic American Offshore Ltd. (NYSE: NAO) dropped about 2.8% Friday, to post a new 52-week low of $1.05 after closing at $1.08 on Thursday. The stock’s 52-week high is $5.69. Volume was about 4 times the daily average of around 490,000 shares. The company had no specific news.

top stocks to invest in now: AMAG Pharmaceuticals, Inc.(AMAG)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) were down around 36 percent to $22.95. Before the open, the issue company issued FY 2017 sales that surrounded current estimates. Also, the company announced an exclusive licensing agreement with Palatin Technologies, Inc. (NYSE: PTN) for North American rights to Rekyndatm. Raymond James downgraded AMAG Pharmaceuticals from Market Perform to Underperform.

  • [By WWW.MONEYSHOW.COM]

    Makena is the flagship drug from AMAG Pharmaceuticals (AMAG); the drug helps reduce the risk of preterm birth.

    The company’s blood registry preserves newborn stem cells used to treat blood and immune disorders.

top stocks to invest in now: Electro Scientific Industries, Inc.(ESIO)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pro (EOP) portfolio newsletter has suggestedsmall cap laser-based manufacturing solutions stockElectro Scientific Industries (NASDAQ: ESIO). According tothe Company itself: Its integrated solutions allow industrial designers and process engineers to control the power of laser light to transform materials in ways that differentiate their consumer electronics, wearable devices, semiconductor circuits and high-precision components for market advantage. The Company’s laser-based manufacturing solutions feature the micro-machining industry’s highest precision and speed, and target the lowest total cost of ownership.To put that more into layman terms: Electro Scientific Industries systems enable precise engineering and testing of micron to submicron features in semiconductors, LEDs, multi-layer ceramic capacitors (MLCCs), printed circuit boards (PCBs), flex circuits and other high-value components – all of which are vital to our economy.

top stocks to invest in now: World Energy Solutions Inc(DE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Deere & Company (NYSE: DE) reported better-than-expected results for its first quarter and lifted its outlook for fiscal 2017.

    Deere’s quarterly net income dropped to $193.8 million, or $0.61 per share, compared to $254.4 million, or $0.80 per share, in the year-ago quarter.

  • [By Lisa Levin]

    Deere & Company (NYSE: DE) reported better-than-expected results for its fourth quarter on Wednesday.

    Deere reported Q4 earnings of $1.57 per share on revenue of $8.018 billion. However, analysts were expecting a profit of $1.47 per share on sales of $7.05 billion.

  • [By JJ Kinahan]

    Earnings season is slowing down, but there’s still a few companies left to report. On Friday, we’ll get a look at the state of agriculture with Deere & Company (NYSE: DE).  And if you have time, make sure to check out today’s market update to see what else is happening.

top stocks to invest in now: China Advanced Construction Materials Group, Inc.(CADC)

Advisors’ Opinion:

  • [By Lisa Levin]

    China Advanced Constructn Mtrls Grp Inc (NASDAQ: CADC) shares shot up 225 percent to $7.15 after gaining 2.33 percent on Wednesday.

    Shares of Smart Global Holdings Inc (NASDAQ: SGH) got a boost, shooting up 29 percent to $36.98 after the company issued strong guidance. The company updated Q1 guidance, raising adjusted EPS from 79 cents-83 cents to 90 cents-93 cents. Sales guidance was raised from $225 million-$240 million to $250 million-$260 million.

how to invest your money

International Business Machines (NYSE:IBM) is still struggling to reach the point where its growth businesses fully offset decreases in legacy revenue. The first quarter, results for which IBM reported last week, marked the 20thconsecutive quarterly revenue decline.

IBM has also extended another streak, one that should make investors happy. The company announced that it was boosting its quarterly dividend payment to $1.50 per share, a 7.1% increase that brings the dividend yield up to about 3.7%. IBM has now increased its dividend annually for 22 years in a row, and it’s paid a quarterly dividend uninterrupted since 1916. Even with dividend growth slowing, IBM is a solid dividend stock that just got even better.

Image source: IBM.

Slowing dividend growth

On a percentage basis, the latest dividend increase is the smallest in over a decade. IBM’s earnings have declined in each of the past three years, so this shouldn’t come as a surprise.

how to invest your money: China Advanced Construction Materials Group, Inc.(CADC)

Advisors’ Opinion:

  • [By Lisa Levin]

    China Advanced Constructn Mtrls Grp Inc (NASDAQ: CADC) shares shot up 225 percent to $7.15 after gaining 2.33 percent on Wednesday.

    Shares of Smart Global Holdings Inc (NASDAQ: SGH) got a boost, shooting up 29 percent to $36.98 after the company issued strong guidance. The company updated Q1 guidance, raising adjusted EPS from 79 cents-83 cents to 90 cents-93 cents. Sales guidance was raised from $225 million-$240 million to $250 million-$260 million.

how to invest your money: Mallinckrodt plc(MNK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today after its earnings topped the Street consensus but offered commentary that spooked investors.

    Agence France-Presse/Getty Images

    Shares of Mallinckrodt dropped 9.1% to $52.42, while the S&P 500 rose 0.1%.

    Barclays analyst Douglas Tsao and Morgan Williams callMallinckrodt’s plunge “outsized.” They explain why:

    In our view the sell-off afterMallinckrodt reported CY3Q16 earnings is outsized considering much of the disclosure on the call was largely expected, including specialty generics weakness and the 2017 outlook, which seemed relatively mild. While outsized Acthar contribution to EBITDA may be accounting for some of the sell-off, wed argue that there is benefit to the brand outperforming, especially considering the need to offset Therakos production issues in CY4Q16 and CY1Q17 as well as specialty generics weakness. We recognize some lingering headline risk associated with media reports criticizing the cost of Acthar to Medicare, after CMS released its prescription drug spending dashboard.

    Mallinckrodt’s market capitalization fell to $5.7 billion today from $6.2 billion yesterday. It reported net income of $306 million on revenue of $3.3 billion in 2015.

    This marks the third time in less than two weeks that Mallinckrodt was the S&P 500′s biggest loser.

  • [By Keith Speights]

    That’s the question investors are trying to answer about how President Trump’s policies might impact healthcare stocks. So far, specific policy proposals put forward by the president appear likely to cause significant problems for certain healthcare stocks. Here’s why three of President Trump’s policies could be downright terrible for Molina Healthcare(NYSE:MOH), Mallinckrodt (NYSE:MNK), and Illumina (NASDAQ:ILMN).

  • [By Paul Ausick]

    Mallinckrodt plc (NYSE: MNK) dropped 39% Tuesday to post a new 52-week low of $19.01 after closing at $31.18 on Monday. The 52-week high is $68.12. Volume was around 32 million, about 16 times the daily average of about 2 million. The generic drug maker missed analysts revenue estimate.

  • [By Johanna Bennett]

    Sell-side analysts continue to defend drug maker Mallinckrodts (MNK) shares on the heel of Citron Researchs report on the company released last week.

    Earlier today, UBS analyst Marc Goodman and his team weighed into the fray, proclaiming that a misunderstood situation creates opportunity.

    Goodman, who rates Mallinckrodt at a buy with a $92 price target, argues that Mallinckrodt is a different breed from other specialty drug makers, with high-quality earnings, sales growth fueled by volume not price hikes and an emerging pipeline we think is not just underappreciated but really not even part of the conversation with most investors.

    Also, he argues that Mallinckrodt continues to be misunderstood by investors.

    Goodman goes into goes into more detail:

    we were surprised this past week by the debate around Acthar’s Medicare exposure (~30% or ~40%), which in our view has little relevance to the overall MNK story. The key debate since the Questcor deal has been Acthar payer coverage and concerns for more barriers andor coverage blocks by the payers. There was reason for concern just 2 years ago, in our view, as several important payers increased barriers. But mgt’s aggressive focus on enhancing clinical and health-economics data to help support better coverage seems to be working and has resulted in improved coverage, which we believe is still not well appreciated.

    Mallinckrodt shares continue to climb today, rising 4.8% to a recent $57.20.

how to invest your money: STARWOOD PROPERTY TRUST, INC.(STWD)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Starwood Property Trust (STWD) is a finance REIT, which means it makes or owns real estate mortgages rather than owning commercial property. The bulk of Starwood Property’s business is to make and hold commercial property mortgages.

how to invest your money: Xylem Inc.(XYL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Technology and Industrials are our favorite ways to buy cyclical MO. Specifically, we see the Technology Select Sector SPDR ETF (XLK) as an attractive pre-breakout idea and a likely candidate to lead the S&Ps secular advance over the coming years. Buy ideas at the stock level include: Accenture (ACN), Broadcom (AVGO), Microsoft , Texas Instruments (TXN),Visa (V),Yahoo! (YHOO). We also recommend buying the Industrial Select Sector SPDR ETF (XLI) which is reversing its year-long downtrend and in position for new highs over the coming months, in our view. Buy ideas at the stock level include: Honeywell International, Ingersoll-Rand (IR), Illinois Tool Works (ITW), 3M, Southwest Airlines (LUV), Xylem (XYL). Underlined stocks are fundamentally-rated Outperform at Oppenheimer.

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

intraday trading

A deceleration in the pace of U.S. corporate stock repurchases is a worrisome sign, according to analysts at Bank of America Merrill Lynch.

In a note to clients last week, strategists at Bank of America Merrill Lynch said the percentage of companies buying back shares peaked in 2015 at nearly 70%. Such peaks historically precede market tops, the analysts warned. Meanwhile, the amount spent on buybacks has been steadily declining, though S&P 500
SPX, +0.61%
companies are still spending more than $100 billion every quarter.

intraday trading: Integrated Device Technology, Inc.(IDTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Analysts are expecting Discovery Communications Inc. (NASDAQ: DISCA) to have earned $0.47 per share on revenue of $1.69 billion in the latest quarter. Discovery Communications shares rose 0.17 percent to $29.08 in after-hours trading.
    Analysts expect T-Mobile US Inc (NASDAQ: TMUS) to report

  • [By Lisa Levin]

     

    T-Mobile US Inc (NYSE: TMUS) reported upbeat earnings for its fourth quarter on Tuesday.
    Integrated Device Technology Inc (NASDAQ: IDTI) agreed to acquire GigPeak Inc (NYSE: GIG) for around $250 million in cash.
    Charles River Laboratories Intl. Inc (NYSE: CRL) reported better-than-expected profit for its fourth quarter.
    Amkor Technology, Inc. (NASDAQ: AMKR) posted downbeat revenue for its fourth quarter and issued a weak outlook for the current quarter.

intraday trading: Marathon Petroleum Corporation(MPC)

Advisors’ Opinion:

  • [By Stephen Mack]

    We’ve seen this happen before. In December, shares of Russian oil company Rosneft jumped 21% in two weeks when it was acquired by Glencore Plc. (LON: GLEN). And back in 2015, MarkWest Energy Partners LP (NYSE: MWE) enjoyed a similar jump when it was acquired by Marathon Petroleum Corp (NYSE: MPC).

  • [By WWW.MONEYSHOW.COM]

    Marathon Petroleum Corporation (MPC) is an American petroleum refining, marketing, and transportation company headquartered in Findlay, Ohio, explains dividend reinvestment expert Vita Nelson, editor of DirectInvesting.

intraday trading: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ: APOP) shares were also up, gaining 135 percent to $7.79 after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.

  • [By Chris Lange]

    Cellect Biotechnology Ltd. (NASDAQ: APOP) reported that it received a formal notice from the U.S. Patent and Trademark Office (USPTO)regarding its method of treatment for immune related disorders. Basically, the USPTO gave a notice of allowance which broadly means the agency intends to issue a patent approval. The treatment method relates to the engineering of regulatory immune cells with enhanced apoptotic activity used for the treatment or prevention for the unmet needs seen in type 1 diabetes, inflammatory bowel disease, graft versus host disease, and transplant rejection.

intraday trading: China Advanced Construction Materials Group, Inc.(CADC)

Advisors’ Opinion:

  • [By Lisa Levin]

    China Advanced Constructn Mtrls Grp Inc (NASDAQ: CADC) shares shot up 225 percent to $7.15 after gaining 2.33 percent on Wednesday.

    Shares of Smart Global Holdings Inc (NASDAQ: SGH) got a boost, shooting up 29 percent to $36.98 after the company issued strong guidance. The company updated Q1 guidance, raising adjusted EPS from 79 cents-83 cents to 90 cents-93 cents. Sales guidance was raised from $225 million-$240 million to $250 million-$260 million.

Mid-Afternoon Market Update: Dow Surges 200 Points; SMART Global Shares Jump On Strong Guidance

Toward the end of trading Thursday, the Dow traded up 0.86 percent to 23,471.49 while the NASDAQ climbed 1.38 percent to 6,798.83. The S&P also rose, gaining 0.89 percent to 2,587.40.

Leading and Lagging Sectors

Thursday afternoon, the cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Griffon Corporation (NYSE: GFF) and Iconix Brand Group Inc (NASDAQ: ICON).

In trading on Thursday, energy shares were relative laggards, down on the day by about 0.18 percent. Meanwhile, top losers in the sector included PrimeEnergy Corporation (NASDAQ: PNRG), down 8 percent, and Aegean Marine Petroleum Network Inc. (NYSE: ANW) down 3 percent.

Top Headline

Wal-Mart Stores Inc (NYSE: WMT) reported better-than-expected earnings for its third quarter and lifted its full-year earnings forecast.

Wal-Mart posted quarterly adjusted earnings of $1 per share on revenue of $123.2 billion. However, analysts were expecting earnings of $0.97 per share on revenue of $121 billion. Comparable store sales rose 2.7 percent in the quarter.

It now projects full-year earnings of $4.38 to $4.46, versus its prior forecast of $4.30 to $4.40 per share.

Equities Trading UP

China Advanced Constructn Mtrls Grp Inc (NASDAQ: CADC) shares shot up 225 percent to $7.15 after gaining 2.33 percent on Wednesday.

Shares of Smart Global Holdings Inc (NASDAQ: SGH) got a boost, shooting up 29 percent to $36.98 after the company issued strong guidance. The company updated Q1 guidance, raising adjusted EPS from 79 cents-83 cents to 90 cents-93 cents. Sales guidance was raised from $225 million-$240 million to $250 million-$260 million.

RH (NYSE: RH) shares were also up, gaining 26 percent to $104.70 after the company increased its outlook for third quarter and fiscal 2017.

Equities Trading DOWN

Intec Pharma Ltd (NASDAQ: NTEC) shares dropped 25 percent to $5.57. Intec Pharma reported a Q3 loss of $0.29 per share.

Shares of Diplomat Pharmacy Inc (NYSE: DPLO) were down 23 percent to $14.71. Diplomat Pharmacy agreed to buy LDI Integrated Pharmacy Services. Baird downgraded Diplomat Pharmacy from Outperform to Neutral.

AxoGen, Inc. (NASDAQ: AXGN) was down, falling around 10 percent to $22.42. AxoGen reported a proposed public offering of common stock.

Commodities

In commodity news, oil traded down 0.36 percent to $55.13 while gold traded up 0.21 percent to $1,280.40.

Silver traded up 0.73 percent Thursday to $17.095, while copper fell 0.39 percent to $3.065.

Eurozone

European shares closed higher today. The eurozone’s STOXX 600 surged 0.78 percent, the Spanish Ibex Index rose 0.75 percent, while Italy’s FTSE MIB Index rose 0.22 percent. Meanwhile the German DAX climbed 0.55 percent, and the French CAC 40 surged 0.66 percent while U.K. shares rose 0.19 percent.

Economics

Initial jobless claims gained 10,000 to 249,000 in the latest week. However, economists were expecting claims to reach 235,000 last week.

The Philly Fed manufacturing index dropped to 18.90 in November, versus prior reading of 27.90. Economists projected a reading of 25.00.

The import price index increased 0.2 percent for October, while export price index was flat.

U.S. industrial production rose 0.9 percent for October, beating economists’ expectations for a 0.6 percent gain.

The NAHB housing market index gained two points to 70 in November. Economists expected a reading of 67.

Domestic supplies of natural gas declined 18 billion cubic feet for the week ended November 10, the U.S. Energy Information Administration reported. Analysts expected a drop of 14 billion cubic feet.

Federal Reserve Governor Lael Brainard is set to speak in Ann Arbor, Michigan at 3:45 p.m. ET.

Data on money supply for the recent week will be released at 4:30 p.m. ET.